arrow
S

Stéphanie Raymond

universite de toulouse (epe)
H指数:25
被引数:1,971

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A multicohort phase II trial of androgen deprivation therapy (ADT), docetaxel (DOCE) and nivolumab (NIVO) in patients (pts) with newly diagnosed metastatic hormone sensitive prostate cancer (mHSPC) enriched for inflamed tumours and DNA damage repair (DDR) alterations: Cohort 3 results

一项多队列II期临床试验,研究雄激素剥夺疗法(ADT)、多西他赛(DOCE)和纳武利尤单抗(NIVO)在富集了炎症肿瘤和DNA损伤修复(DDR)改变的新诊断转移性激素敏感性前列腺癌(mHSPC)患者(pts)中的应用:队列3结果

2024-09-010
PRE
DORAVIR: a French national survey of people with HIV-1 treated with an antiretroviral regimen including doravirine
2024-06-170
PRE
Factors associated with the emergence of integrase resistance mutations in patients failing dual or triple integrase inhibitor-based regimens in a French national survey
2021-07-079
OA
Setting the standard: multidisciplinary hallmarks for structural, equitable and tracked antibiotic policy

制定标准: 结构,公平和跟踪抗生素政策的多学科标志

2020-09-2356
OAAI